Infertility: Management: Difference between revisions

Line 99: Line 99:
*Benefits of supplements (e.g., vitamins, antioxidants, nutritional supplement formulations) are of questionable clinical utility[https://pubmed.ncbi.nlm.nih.gov/33295257/ §]
*Benefits of supplements (e.g., vitamins, antioxidants, nutritional supplement formulations) are of questionable clinical utility[https://pubmed.ncbi.nlm.nih.gov/33295257/ §]
===Treatment Selection'''<span style="color:#ff0000">[https://pubmed.ncbi.nlm.nih.gov/33295257/ ★]</span>'''===
===Treatment Selection'''<span style="color:#ff0000">[https://pubmed.ncbi.nlm.nih.gov/33295257/ ★]</span>'''===
*'''Testosterone monotherapy should not be prescribed for the male interested in current or future fertility[https://pubmed.ncbi.nlm.nih.gov/33295257/ §]'''
*'''<span style="color:#ff0000">Testosterone monotherapy should not be prescribed for the male interested in current or future fertility</span>[https://pubmed.ncbi.nlm.nih.gov/33295257/ §]'''
**Exogenous testosterone administration provides negative feedback to the hypothalamus and pituitary gland, which can result in inhibition of gonadotropin secretion.
**Exogenous testosterone administration provides negative feedback to the hypothalamus and pituitary gland, which can result in inhibition of gonadotropin secretion.
**Depending on the degree of testosterone-induced suppression, spermatogenesis may decrease or cease altogether, resulting in azoospermia.
**Depending on the degree of testosterone-induced suppression, spermatogenesis may decrease or cease altogether, resulting in azoospermia.